Prostate Cancer - Results from #780

Automated prostate gland segmentation in challenging clinical cases: comparison of three artificial intelligence methods. June 4, 2024

An artificial intelligence model for detecting pathological lymph node metastasis in prostate cancer using whole slide images: a retrospective, multicentre, diagnostic study. June 4, 2024

An integrated radiology-pathology machine learning classifier for outcome prediction following radical prostatectomy: Preliminary findings. June 4, 2024

Proposal for an optimised definition of adverse pathology (unfavourable histology) that predicts metastatic risk in prostatic adenocarcinoma independent of grade group and pathological stage. June 4, 2024

Knowledge and practices regarding prostate cancer screening in Spanish men: The importance of personal and clinical characteristics (PROSHADE study). June 3, 2024

Patient-reported Outcome Measures and Experience Measures After Active Surveillance Versus Radiation Therapy Versus Radical Prostatectomy for Prostate Cancer: A Systematic Review of Prospective Comparative Studies. June 3, 2024

Long-Term Outcomes in Patients Using Protocol-Directed Active Surveillance for Prostate Cancer. June 3, 2024

International Variations in Surgical Quality of Care in Men With Prostate Cancer: Results From the TrueNTH Global Registry. June 3, 2024

Prostate Cancer Foundation Screening Guidelines for Black Men in the United States. June 3, 2024

In vivo genome-wide CRISPR screening identifies CITED2 as a driver of prostate cancer bone metastasis. May 31, 2024

Unveiling Novel Double-Negative Prostate Cancer Subtypes Through Single-Cell RNA Sequencing Analysis. May 31, 2024

Reproducible preclinical models of androgen receptor driven human prostate cancer bone metastasis. May 31, 2024

Cyclin-dependent kinase 12 deficiency reprogrammes cellular metabolism to alleviate ferroptosis potential and promote the progression of castration-resistant prostate cancer. May 31, 2024

Capivasertib in combination with enzalutamide for metastatic castration resistant prostate cancer after docetaxel and abiraterone: Results from the randomized phase II RE-AKT trial. May 31, 2024

Urinary and Sexual Impact of Robotic Radical Prostatectomy: Reporting of Patient-reported Outcome Measures in the First Year after Radical Prostatectomy in a Contemporary Multicentre Cohort in the United Kingdom. May 31, 2024

Oncological and Functional Outcomes of Whole-Gland HIFU as the Primary Treatment for Localized Prostate Cancer: A Systematic Review. May 31, 2024

Impact of PSA nadir, PSA response and time to PSA nadir on overall survival in real-world setting of metastatic hormone-sensitive prostate cancer patients. May 31, 2024

Combined holmium laser enucleation of the prostate with high-intensity focused ultrasound in treating patients with localized prostate cancer in a prostate with volume > 60 g: Oncological and functional outcomes from single-institution study. May 31, 2024

Marijuana Use May Be Associated with Reduced Prevalence of Prostate Cancer: A National Survey on Drug Use and Health Study from United States of America. May 31, 2024

AR loss in prostate cancer stroma mediated by NF-κB and p38-MAPK signaling disrupts stromal morphogen production. May 30, 2024

Page 40 of 1435